Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Timing bond vs index fund choices in retirement affects risk and growth. Learn when to shift allocations for income.
25,546 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A sweeping regulatory bill could transform how Russians trade and use digital assets. As two votes stand between now ...
A $22 million foster care village backed by actor Christian Bale is on track to finish this year, aiming to keep sibl...
New Mexico moves to examine decades of coerced sterilizations in Native communities, with findings due by 2027. The i...
Georgia lawmakers revived a constitutional amendment aimed at protecting LIHTC properties from steep property tax hik...
Paramount has emerged as the apparent victor in a months-long bidding war to buy Warner Bros. Discovery’s film and TV...
Markets in March 2026 are volatile, pushing traders to seek reliable borrow access and fast execution. This article i...
Bitcoin again cannot break the $71,500 ceiling, underscoring a stubborn resistance amid a broader risk-off shift. The...
Bitcoin steadies around the mid-50s as XRP, Solana, and PEPE push higher on evolving policy signals and renewed inves...
Ethereum faces a potential slide toward $1,500 by the end of the third quarter if bearish momentum persists. CryptoQu...
Meta Platforms is considering cutting up to 20% of its workforce to fund AI infrastructure through 2028. The move mir...
RunSybil secures $40 million in a funding round led by Khosla Ventures, backing its autonomous AI agents that hack li...